+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05746442

Evaluating Smartphone-Based Tailored Messaging and Nicotine Patches to Help Cambodian People Living with HIV Quit Smoking

Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-08-13

800

Participants Needed

3

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how well an automated text messaging program delivered via smartphone helps Cambodian people living with HIV quit smoking. This study focuses on smokers who are HIV-positive and aims to prevent tobacco use by comparing a tailored messaging program with standard care. The study is sponsored by the H. Lee Moffitt Cancer Center and Research Institute and uses a randomized design. Participants are assigned to one of two groups. One group receives brief advice, educational materials, weekly assessments on a smartphone, and an 8-week supply of nicotine patches. The other group receives the same brief advice and nicotine patches but also uses an interactive smartphone messaging program for 26 weeks that provides personalized messages to increase motivation, coping skills, social support, and reduce withdrawal symptoms. Both groups complete weekly diet assessments via smartphone during the 26-week period. Throughout the study, participants complete assessments of smoking status using self-reported 7-day abstinence and expired carbon monoxide at 3, 6, and 12 months. Researchers monitor smoking cessation outcomes and adherence to the interventions. The total study duration extends up to 12 months, with ongoing data collection to evaluate smoking abstinence. Safety is monitored through exclusion criteria related to medical conditions affecting nicotine patch use.

CONDITIONS

Brief Title

Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS

Research Team

L

Lindsey Sparrock, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here